Mega Lifesciences Public Company Limited (MEGA.BK)
THB 32.75
(0.0%)
THB 32.75
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.07 Billion THB | -6.51% |
| 2022 | 4.35 Billion THB | 15.63% |
| 2021 | 3.76 Billion THB | 14.24% |
| 2020 | 3.29 Billion THB | 3.87% |
| 2019 | 3.17 Billion THB | -2.05% |
| 2018 | 3.24 Billion THB | 9.39% |
| 2017 | 2.96 Billion THB | 10.86% |
| 2016 | 2.67 Billion THB | -1.61% |
| 2015 | 2.71 Billion THB | 9.46% |
| 2014 | 2.48 Billion THB | 11.06% |
| 2013 | 2.23 Billion THB | 12.92% |
| 2012 | 1.98 Billion THB | 12.78% |
| 2011 | 1.75 Billion THB | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.06 Billion THB | -3.44% |
| 2024 Q2 | 1.13 Billion THB | 6.89% |
| 2023 Q3 | 1.02 Billion THB | -1.68% |
| 2023 Q4 | 1.1 Billion THB | 8.18% |
| 2023 FY | 4.07 Billion THB | -6.51% |
| 2023 Q1 | 1.02 Billion THB | -13.75% |
| 2023 Q2 | 1.03 Billion THB | 1.02% |
| 2022 Q3 | 1.09 Billion THB | 0.95% |
| 2022 Q1 | 988.77 Million THB | 9.79% |
| 2022 Q2 | 1.08 Billion THB | 9.63% |
| 2022 Q4 | 1.19 Billion THB | 8.89% |
| 2022 FY | 4.35 Billion THB | 15.63% |
| 2021 Q2 | 954.17 Million THB | 14.36% |
| 2021 Q3 | 1.08 Billion THB | 13.21% |
| 2021 Q4 | 900.58 Million THB | -16.63% |
| 2021 FY | 3.76 Billion THB | 14.24% |
| 2021 Q1 | 834.32 Million THB | -8.32% |
| 2020 Q1 | 789.59 Million THB | 1.28% |
| 2020 FY | 3.29 Billion THB | 3.87% |
| 2020 Q2 | 747.1 Million THB | -5.38% |
| 2020 Q3 | 850.92 Million THB | 13.9% |
| 2020 Q4 | 910.08 Million THB | 6.95% |
| 2019 Q4 | 779.61 Million THB | -4.86% |
| 2019 Q3 | 819.42 Million THB | 0.55% |
| 2019 FY | 3.17 Billion THB | -2.05% |
| 2019 Q2 | 814.94 Million THB | 5.49% |
| 2019 Q1 | 772.52 Million THB | -7.94% |
| 2018 Q2 | 810.95 Million THB | 8.48% |
| 2018 FY | 3.24 Billion THB | 9.39% |
| 2018 Q4 | 839.12 Million THB | -0.72% |
| 2018 Q3 | 845.2 Million THB | 4.22% |
| 2018 Q1 | 747.59 Million THB | -5.4% |
| 2017 FY | 2.96 Billion THB | 10.86% |
| 2017 Q1 | 688.66 Million THB | -8.69% |
| 2017 Q2 | 742.21 Million THB | 7.78% |
| 2017 Q3 | 743.39 Million THB | 0.16% |
| 2017 Q4 | 790.26 Million THB | 6.3% |
| 2016 Q1 | 596.87 Million THB | -12.62% |
| 2016 Q2 | 639.58 Million THB | 7.16% |
| 2016 Q3 | 683.45 Million THB | 6.86% |
| 2016 Q4 | 754.19 Million THB | 10.35% |
| 2016 FY | 2.67 Billion THB | -1.61% |
| 2015 Q2 | 695.24 Million THB | 15.07% |
| 2015 Q4 | 683.08 Million THB | -7.52% |
| 2015 Q3 | 738.64 Million THB | 6.24% |
| 2015 Q1 | 604.17 Million THB | -4.88% |
| 2015 FY | 2.71 Billion THB | 9.46% |
| 2014 Q2 | 608.23 Million THB | 3.67% |
| 2014 FY | 2.48 Billion THB | 11.06% |
| 2014 Q4 | 635.18 Million THB | -2.71% |
| 2014 Q3 | 652.85 Million THB | 7.34% |
| 2014 Q1 | 586.69 Million THB | -4.67% |
| 2013 Q4 | 615.4 Million THB | 10.2% |
| 2013 Q3 | 558.42 Million THB | 2.83% |
| 2013 Q1 | 518.89 Million THB | -8.99% |
| 2013 FY | 2.23 Billion THB | 12.92% |
| 2013 Q2 | 543.03 Million THB | 4.65% |
| 2012 FY | 1.98 Billion THB | 12.78% |
| 2012 Q2 | 462.86 Million THB | 0.0% |
| 2012 Q4 | 570.14 Million THB | 6.69% |
| 2012 Q3 | 534.4 Million THB | 15.46% |
| 2011 FY | 1.75 Billion THB | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Mega Lifesciences Public Company Limited | 4.07 Billion THB | 0.0% |